Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Study completedNCT00019552
What this trial is testing

Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Not applicableEnded earlyNCT05124743
What this trial is testing

HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors

Who this might be right for
Ovarian CancerEndometrial CancerColo-rectal Cancer+3 more
Alaunos Therapeutics 19
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Testing effectiveness (Phase 2)Study completedNCT00072566
What this trial is testing

Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal CarcinomaRecurrent Ovarian CarcinomaStage IV Ovarian Cancer
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Ended earlyNCT02978222
What this trial is testing

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Platinum Sensitive Ovarian CancerOvarian Cancer
Marker Therapeutics, Inc. 120
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Study completedNCT02324595
What this trial is testing

Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study

Who this might be right for
Stage IV Ovarian CarcinomaEffects of ChemotherapyPeritoneal Cavity Cancer
Catholic University of the Sacred Heart 30
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableStudy completedNCT00879840
What this trial is testing

Assessment of Screening Modalities for Gynecologic Cancers

Who this might be right for
Ovarian CancerEndometrial CancerControls Without Endometrial Cancer+1 more
National Cancer Institute (NCI) 118
Not applicableUnknownNCT01888159
What this trial is testing

Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve

Who this might be right for
Ovarian Cancer
Karlstad Central Hospital 100
Not applicableEnded earlyNCT02705924
What this trial is testing

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Centre Jean Perrin 32
Testing effectiveness (Phase 2)Looking for participantsNCT07460180
What this trial is testing

The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial CancerFallopian Tube Cancer
The Netherlands Cancer Institute 55
Early research (Phase 1)Ended earlyNCT00003382
What this trial is testing

Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00002559
What this trial is testing

Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

Who this might be right for
Ovarian CancerTesticular Germ Cell Tumor
Memorial Sloan Kettering Cancer Center 43
Testing effectiveness (Phase 2)Ended earlyNCT00194935
What this trial is testing

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Weill Medical College of Cornell University 32
Testing effectiveness (Phase 2)Study completedNCT00010179
What this trial is testing

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663513
What this trial is testing

Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancers
Fudan University 36
Next Page